Growth/Buyout Portfolio - Mabtech

Mabtech is a Swedish biotech company that was founded by scientists at the Department of Immunology, Stockholm University. Since late 2019, the majority owners of Mabtech are IK Investment Partners and Mérieux Equity Partners.

The Mabtech team is dedicated and shares an enthusiasm for biomedical research and science, particularly in the field of immunology. Their mission is to develop monoclonal antibodies and kits for cytokine measurement in order assist other researchers with high-quality, dependable research tools and expert technical support. Since 2018, Mabtech also produces analytical readers for ELISpot and FluoroSpot.

Augustendalstorget 9 - 131 52 Nacka Strand - SWEDEN

www.mabtech.com